Abstract
The in vitro activity of ceftriaxone and six additional antimicrobial agents (ceftizoxime, cefoperazone, cefuroxime, fleroxacin, ciprofloxacin, and trimethoprim/sulfamethoxazole) was assessed or 602 recent clinical isolates of staphylococci from six geographically distinct medical centers in North America. All seven antimicrobial agents were active (90–100% of strains susceptible) against oxacillin-susceptible (OS) strains of Staphylococcus aureus (OSSA) and coagulase-negative staphylococci (OSCNS) but had limited activity against oxacillin resistant (OR) staphylococci. Our assessment of the in vitro antistaphylococcal activity of ceftriaxone against contemporary isolates of Staphylococcus aureus and coagulase-negative staphylococci indicates that the activity versus OS staphylococci has not changed over the past decade despite widespread use of the drug. It appears that these agents will continue to be useful for empiric therapy in those centers in which OR strains are uncommon.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
AngehernP., ProbstP.F., ReinerR. and ThenR.L. (1980): Ro 13–9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies -Antimicrob. Agents Chemother. 18: 913–921.
BarryA.L. and JonesR.N. (1987): In vitro activity of ciprofloxacin against gram-positive cocci - Am. J. Med. 82(Suppl. 4A): 27–32.
BeamT.R., RaabT.A., SpoonerJ.A., BaldermanS.C., AldridgeJ. and BahyanaJ.N. (1984): Comparison of ceftriaxone and cefazolin prophylaxis against infection in open heart surgery - Am. J. Surg. 148: 814.
CleelandR. and SquiresE. (1984): Antimicrobial activity of ceftriaxone: a review - Am. J. Med. 77(4C): 3–11.
FassR.J. (1981): In vitro activity of ceftriaxone (Ro 13–9904), a new cephalosporin, against gram-positive cocci - Curr. Therap. Res. 30: 535–539.
FuchsP.C., JonesR.N., BarryA.L., AyersL.W., GavanT.L., GerlachE.H. and ThornsberryC. (1987): Ro 23–6240 [AM-833], a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretative criteria - Diagn. Microbiol. Infect. Dis. 7: 29–35.
GordinF.M., WofsyC.B. and MillsJ. (1985): Oncedaily ceftriaxone for skin and soft tissue infections -Antimicrob. Agents Chemother. 27: 648–649.
HinkleA.M. and BodeyG.P. (1980): In vitro evaluation of Ro 13–9904 - Antimicrob. Agents Chemother. 18: 574–578.
JonesR.N., BarryA.L. and ThornsberryC. (1983): Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-μg disks - Diagn. Microbiol. Infect. Dis. 1: 295–311.
MaslowM.J., LevineJ.F., PollockA.A., SimberkoffM.S. and RahalJ.J.Jr. (1982): Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections - Antimicrob. Agents Chemother. 22: 103–107.
National Committeefor Clinical Laboratory Standards (1990): Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically -Approved Standard, M7-A2, NCCLS, Villanova, PA.
NeuH.C., MeropolN.J. and FuK.P. (1981): Antibacterial activity of ceftriaxone (Ro 13–9904), a β-lactamase-stable cephalosporin - Antimicrob. Agents Chemother. 19: 414–423.
ShannonK., KingA., WarrenC. and PhillipsL. (1980): In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13–9904 to β-lactamases -Antimicrob. Agents Chemother. 18: 292–298.
Author information
Authors and Affiliations
Additional information
Corresponding author.
Rights and permissions
About this article
Cite this article
Pfaller, M.A., Barry, A.L., Sabath, L.D. et al. In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centers. Eur J Epidemiol 9, 658–662 (1993). https://doi.org/10.1007/BF00211442
Issue Date:
DOI: https://doi.org/10.1007/BF00211442